Position in IMUX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,693,603
+$1,065,467 QoQ
Shares Held
1,525,769
+29.7% QoQ
Ownership
11.2%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMUX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. IMUX ranks #277 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in IMUX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,693,603 | 1,525,769 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $628,136 | 1,176,285 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $911,786 | 1,033,772 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $680,295 | 974,636 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,064,005 | 976,152 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $952,290 | 952,290 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,560,129 | 945,533 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,039,245 | 936,258 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,182,252 | 895,646 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $626,419 | 417,613 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $583,066 | 396,644 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $886,557 | 353,210 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $549,266 | 368,635 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $378,673 | 270,481 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $684,980 | 216,766 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $745,970 | 214,977 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,078,836 | 360,959 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,062,400 | 320,000 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,778,484 | 313,953 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,170,055 | 258,569 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,621,014 | 164,430 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,329,079 | 152,327 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,399,169 | 129,196 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $419,133 | 34,582 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||